WALTHAM, Mass., Dec. 6, 2011 (GLOBE NEWSWIRE) -- ImmunoGen, Inc. (Nasdaq:IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that its presentation at the Oppenheimer 22nd Annual Healthcare Conference at 3:55 pm ET on December 13, 2011 will be webcast live.
